Chest tube clearance system demonstrates value in cardiac surgery study
A trial of ClearFlow's PleuraFlow Active Clearance Technology (ACT) has demonstrated the value in adding the system into Enhanced Recovery After Cardiac Surgery (ERAS) cardiac programme protocols.
Securing US Food and Drug Administration (FDA) clearance in 2010, PleuraFlow ensures that chest tubes are unobstructed in adult cardiac surgery patients and that blood or fluid has been effectively evacuated from surgical sites post-operatively.
The system also functions to reduce retained blood, a known contributor to postoperative complications, including pleural effusions and post-operative atrial fibrillation (POAF).
Conducted at Franciscan Health in Indianapolis, US, ClearFlow's prospective observational study included 1,334 adult cardiac surgery patients. The 650-patient control group received standard drainage while the 684-patient intervention group received PleuraFlow.
In the intervention group, respective reductions of 41%, 30%, and 64% were achieved in the incidence of retained blood syndrome (RBS), median ICU hours, and ICU readmissions.
PleuraFlow also demonstrated a 17% reduction in POAF and a 23% decrease in total chest drainage.
The study findings were published in the journal Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery.
Dr Marc Gerdisch, chief of cardiovascular and thoracic surgery, co-director of the Heart Valve Center at Franciscan Health and principal investigator of the study, commented: 'We studied the clinical outcomes and financial implications of PleuraFlow chest drains when added to our established ERAS cardiac program protocols.'
Research suggests that ERAS protocols result in faster hospital discharge and potentially reductions in surgical complications. The protocol aims to improve recovery and reduce complications following surgery by taking steps to optimise a patient's health before, during, and after the procedure.
Dr Gerdisch continued: 'The unequivocal positive results have led to significantly fewer complications and hospital days. More recently, we have leveraged our confidence that the chest is well drained to achieve a median time to extubation of zero hours. Perhaps most importantly, the bedside nurse can ensure the chest drain is patent.'
In 2016, ClearFlow received an expanded indication clearance from the FDA for PleuraFlow's use in the treatment of paediatric cardiothoracic surgery patients. PleuraFlow ACT remains the only FDA-cleared device indicated to prevent or minimise retained blood in patients recovering from heart surgery.
"Chest tube clearance system demonstrates value in cardiac surgery study" was originally created and published by Medical Device Network, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Axios
43 minutes ago
- Axios
Pennsylvania joins calls to ban food dyes in schools
Pennsylvania schools could soon be banned from offering students food with common food dyes. The big picture: HHS Secretary Robert F. Kennedy Jr. and the Trump administration have launched bids to eliminate synthetic dyes from the food supply and revamp what Americans eat. State of play: The artificial dye ban proposed in the state House would prevent public schools from serving food with the following substances: Blue 1, Blue 2, Green 3, Red 40, Yellow 5 and Yellow 6. Zoom out: Such bans have been a growing trend at the state level. After California passed a first-in-the-nation food dye law two years ago, at least two dozen states have taken up similar legislation. That includes West Virginia, which recently passed a law to ban nine synthetic dyes and additives from food sold in the state. Plus: The FDA recently approved three natural color additives in its effort to eliminate synthetic dyes in foods. Between the lines: Republican state Rep. Natalie Mihalek, who serves part of Allegheny and Washington counties, filed her food-dye ban bill as part of a legislative package of proposals that address the state's food supply. Those proposals include the disclosure of certain chemicals on food labels. Another proposal in the Pennsylvania Senate seeks to allow schools to offer whole and 2% milk that's produced in Pennsylvania. What they're saying: Mihalek tells Axios she became interested in banning food dyes over concerns about what her three school-aged children were eating.
Boston Globe
an hour ago
- Boston Globe
What's going on with measles, bird flu, and COVID? Here's a guide to the latest.
Write to us at . To subscribe, . TODAY'S STARTING POINT Measles outbreaks. A canceled effort to develop a bird flu vaccine. An infectious new COVID variant and changing federal guidance about who should get boosted. In recent weeks, drama in D.C. has buried several vaccine-related developments. Today's newsletter explains what's new and what it means. COVID What's changed: Last month, health secretary Robert F. Kennedy Jr. What it means: The administration has tried to narrow the pool of people it says should get boosted. But where some of the changes reflect reasonable readings of the science, others do not. Advertisement Dr. Nirav Shah, a top CDC official during the Biden administration, said experts debate whether younger children should get boosted. When Shah was in government, he recommended it. But many other countries don't, noting that most young children have a low risk of serious illness. The mRNA technology used in some COVID shots can also have side effects, including a condition called myocarditis that mostly affects boys and young men. Advertisement But Shah, who previously led Maine's CDC and is now at Colby College, says the evidence is much less debatable in the case of pregnant women. Not only are boosters safe and effective for them, but getting them protects babies in utero and up to 6 months old The way Kennedy made the changes has also troubled experts. Normally, health agencies gather outside advisers' input before making new recommendations. But Kennedy seems to have acted unilaterally. His announcement, made in a minutelong social media video, 🎁 ). 'What it suggests is that some of the conclusions are foregone,' Shah said. Kennedy argues that health experts made mistakes that undermined public trust during the pandemic. Shah acknowledges that, to a point. Some experts, he said, tried to squelch dissenting views or didn't effectively communicate that scientists' understanding of COVID would evolve, causing confusion when public health guidance changed. Other experts overstated 🎁 ). But the administration's approach risks sowing further confusion. Kennedy's announcement conflicts with an article that two Trump-appointed FDA officials published days earlier, which listed pregnancy as one factor that puts women ' 'What worries me is that when we get into another emergency situation, if trust in federal health authorities has waned, that's a problem,' Shah said. Advertisement Meanwhile, COVID keeps evolving. A variant called NB.1.8.1 has recently driven up cases in China and elsewhere. But for now, Shah isn't hugely concerned. NB.1.8.1 descended from Omicron, a variant that swept the United States in late 2021 and early 2022. So even if cases rise, existing vaccines and antibodies from prior infection will likely help protect against severe illness. The World Health Organization says the new variant ' Bird flu What's changed: A few months ago, bird flu was spreading rapidly among cows and chickens, What it means: Bird flu may be seasonal, which Given the uncertainty, some experts have faulted the administration for Advertisement Measles What's changed: Cases of the highly contagious virus continue to rise nationwide, but slowly. The largest outbreak, in West Texas, seems to be abating. Three Americans have died this year, all unvaccinated. What it means: A slowing case rate is good news, although many more people could have gotten sick than the official numbers reflect. The measles vaccine is safe, highly effective, and decades old, but Kennedy was slow to full-throatedly recommend it as the outbreak grew. 🧩 3 Down: 90° POINTS OF INTEREST Bob Lamb, who operates his gunsmithing business out of his garage in Cheshire, Mass., says the area has a "hunting culture." Erin Clark/Globe Staff Boston War of words: The US attorney for Massachusetts accused Boston Mayor Michelle Wu of making ' Dueling claims: Democratic activists asked a state agency to investigate Josh Kraft's mayoral campaign for allegedly Secret proceedings: A closed hearing begins in Boston today to determine whether a former Stoughton police deputy chief should lose his ability to work as an officer Evolving: A Boston nonprofit that launched after George Floyd's murder is navigating a backlash to Massachusetts and New England Karen Read retrial: The defense called a snowplow driver, who testified that he Market Basket case: Who's who in the latest Proxy fight: Representative Stephen Lynch of Massachusetts is running to become the top Democrat on an important House committee. His challengers Gun rights: Massachusetts has one of the country's strictest gun-control laws. But guns are ubiquitous in some towns — including Mount Katahdin deaths: Rescuers Trump administration One big bill: Trump's tax cut legislation would add $2.4 trillion to the deficit over the next decade, a nonpartisan congressional agency found. Trump has Latest salvo: Elon Musk urged Republican lawmakers Weaponizing government: Trump directed his administration to investigate Joe Biden and his aides, alleging they hid Biden's decline and that some of his actions weren't legally valid. ( Russia-Ukraine war: Trump spoke with Vladimir Putin and said the Russian leader had pledged to retaliate against Ukraine's drone attack on Russian airfields last weekend. ( Israel-Hamas war: The United States vetoed a UN Security Council resolution that called for an immediate cease-fire in Gaza. ( The Nation and the World Trans rights: Nebraska's governor signed a law banning transgender athletes from girls' sports. About half of states have similar bans. ( Overstaying their welcome: About 400,000 tourists who stayed in the United States longer than their visas allow — like the suspect in the Boulder, Colo., attack did — Explosive find: Officials in Cologne, Germany, temporarily evacuated 20,000 residents after construction work unearthed three unexploded US bombs from World War II. Experts defused them in about an hour. ( BESIDE THE POINT By Teresa Hanafin 💧 More rain this weekend: Either Boston is in 🎵 Rick Astley has the last laugh: 'Never Gonna Give You Up' has hit 1 billion streams on Spotify. 🦈 Films inspired by 'Jaws': From asthmatic sharks to 18-foot bears, here are some of the 🐔 Chicken wars: Mickey D's is bringing back the Snack Wrap after nine years because of demand — and the success of similar wraps from Burger King and Wendy's. ( 🏠 3 summer home rehabs: In downtown Burlington, Vt., Advertisement ⛱️ Beach etiquette: Don't encroach, block views, shake sand, disrespect wildlife, or do other things that are hallmarks of an obnoxious beachgoer. ( Thanks for reading Starting Point. NOTE: A 🎁 emoji indicates a gift link. A $ is a subscription site that does not offer gift links. This newsletter was edited and produced by ❓ Have a question for the team? Email us at ✍🏼 If someone sent you this newsletter, you can 📬 Delivered Monday through Friday. Ian Prasad Philbrick can be reached at
Wall Street Journal
2 hours ago
- Wall Street Journal
A New Shot Prevents HIV—and Breathes New Life Into a Stagnant Biotech
Later this month, the Food and Drug Administration is widely expected to approve a groundbreaking twice-yearly injection to prevent HIV—a milestone in the decadeslong fight against a once-devastating disease. For Gilead Sciences GILD -0.28%decrease; red down pointing triangle, the dominant player in HIV treatment, the breakthrough is doing what years of splashy but underwhelming acquisitions failed to achieve: It has Wall Street paying attention again. Since reporting last June that just two annual shots of lenacapavir prevented all HIV infections in a study of women and girls, shares have surged 73%.
